P&T
Our
Other
Journal
MediMedia Managed Markets

 

Reversing Asthma-Related Morbidity and Mortality Through Patient Persistency

Reversing Asthma-Related Morbidity and Mortality Through Patient Persistency

A panel of experts gathered to discuss challenges in asthma management, including disease variability, appropriateness of the National Asthma Education and Prevention Program guidelines, patient compliance, and accuracy of pharmacy claims data as a basis of severity classification.

The panelists discussed revising the asthma classification system and initiation of corresponding changes in treatment recommendations. Important studies were examined, highlighting compliance variations relative to pharmacotherapeutic options, the association between treatment and outcomes, the effect of nonreported short-acting beta2 agonist use on asthma classifications and outcomes data, and quality-of-life issues for different initial maintenance therapies. Also, the panel looked at methods of analyzing data on asthma management from individual health plans, outlining how other health plans can apply these insights.

Highlights:

  • Understanding Asthma Severity — Variability of Classifications and Outcomes
  • The Truth About SABA Pharmacy Claims — Results from a Prospective Study
  • Guidelines, Treatment Options, and Outcomes Data — a Health Planís Perspective
  • Roundtable Discussion: Challenges: Classification, Persistency, and Perceptions of Disease Control